Blockchain Registration Transaction Record

Cybin Collaborates with Thermo Fisher for Clinical Supply of CYB003 Treatment

Cybin partners with Thermo Fisher Scientific for Phase 3 clinical supply of CYB003, a deuterated psilocin treatment for major depressive disorder. The collaboration aims to revolutionize mental healthcare through innovative drug development.

This news highlights the progress in developing innovative psychedelic-based therapeutics for mental health conditions, addressing the significant unmet need in the field. The partnership with Thermo Fisher enhances Cybin's manufacturing capabilities, potentially advancing the treatment for major depressive disorder and offering hope for patients struggling with the condition.